CONJUGATES OF WATER SOLUBLE POLYMER-AMINO ACID OLIGOPEPTIDE-DRUG, PREPARATION METHOD AND USE THEREOF
申请人:JENKEM TECHNOLOGY CO. LTD. TIANJIN BRANCH
公开号:US20150359900A1
公开(公告)日:2015-12-17
A conjugate of water soluble polymer-amino acid oligopeptide-drug of Formula (I) below and a pharmaceutical composition comprising the conjugate are provided. In the conjugate, P is a water soluble polymer; X is a linking group, wherein the linking group links P and A
1
; each of A
1
, A
2
and A
3
is independently same or different amino acid residue or amino acid analogue residue; each of D
1
and D
2
is independently same or different drug molecule residue; a is 0 or 1; b is an integer of 2-12; c is an integer of 0-7; d is 0 or 1. The conjugate could improve drug load capacity, water solubility, stability and activity of the drug.
strategy for oxidative Csp2-H arylation of electron-rich furans and pyrroles has been achieved with the aid of remote carbonyl-containing groups. These groups enable the Pd-catalyzed oxidative Csp2-H arylation of furans to proceed under a warm temperature and O2 atmosphere, while distinctly promoting the yield of such a reaction for pyrroles. Supported by the experimental results and density functional
借助远程含羰基基团,已经实现了富电子呋喃和吡咯的氧化 C sp2 -H 芳基化的温和策略。这些基团使 Pd 催化的呋喃氧化 C sp2 -H 芳基化能够在温暖的温度和 O 2下进行气氛,同时明显提高吡咯反应的产率。在实验结果和密度泛函理论计算的支持下,针对这些转换提出了一个原始概念,即远程组辅助 Heck 型路径。此外,发现包括芳基硼酸在内的富电子底物作为芳基化试剂具有良好的耐受性,该策略也已应用于合成 S-亚硝基谷胱甘肽还原酶抑制剂骨架的替代途径。
SOME ADDITION AND CYCLIZATION REACTIONS OF 1,4-DIBENZOYL-1,3-BUTADIENE<sup>1</sup>
作者:PHILIP S. BAILEY、WAFAI W. HAKKI、HOWARD W. BOST
DOI:10.1021/jo01365a014
日期:1955.8
HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
申请人:Yu, Chongxi
公开号:EP2370406A1
公开(公告)日:2011-10-05
Castration-Resistant Prostate Cancer
申请人:NUtech Ventures
公开号:US20160310528A1
公开(公告)日:2016-10-27
This invention relates to inhibitors of UDP-glucose dehydrogenase, and more particularly to UDP-glucose dehydrogenase inhibitors that are useful in the treatment of prostate cancer. Methods of inhibiting UDP-glucose dehydrogenase and improving the efficacy of additional prostate cancer therapies are also provided.